Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery?

Toby Steele, Jess C. Mace, Adam S. Deconde, Christopher C. Xiao, Kristina A. Storck, David A. Gudis, Rodney J. Schlosser, Zachary M. Soler, Timothy L. Smith

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Both obesity and chronic rhinosinusitis (CRS) are characterized by inflammation. Furthermore, both disease processes are independently associated with decreases in quality-of-life (QOL). We sought to investigate the role of comorbid obesity in QOL outcomes in CRS patients undergoing endoscopic sinus surgery (ESS). Methods: Adult patients with medically refractory CRS (n = 241) were prospectively enrolled into a multi-institutional treatment outcomes investigation. Body mass index (BMI) calculations were used to differentiate patient weight groups (normal weight: 18.5 to 24.9, overweight: 25.0 to 29.9; and obese: ≥30.0). Preoperative and postoperative QOL (Rhinosinusitis Disability Index [RSDI] and the 22-item Sino-Nasal Outcome Test [SNOT-22]) were evaluated compared across BMI groups and obesity subclasses. Results: The prevalence of comorbid obesity was 41% (n = 99). Higher prevalence of comorbid disease was found across increasing BMI groups including diabetes mellitus, asthma, and depression. No significant differences were found in mean preoperative QOL measures between any BMI groups. Significant improvement between preoperative and postoperative QOL mean scores (p ≤ 0.050) was found for all BMI groups. Despite no significant difference in mean QOL improvement between BMI groups (p ≥ 0.142), overweight and obese patients reported reduced relative mean percentage (%) improvement compared to normal weight participants on the RSDI total score (33% and 37% vs 55%, respectively) and SNOT-22 total score (29% and 40% vs 48%, respectively). Conclusion: Patients with comorbid obesity experience significant improvement in average QOL gains following ESS though the percentage of relative improvement in QOL may be decreased in patients with comorbid obesity and CRS as compared to those without.

Original languageEnglish (US)
Pages (from-to)1085-1094
Number of pages10
JournalInternational Forum of Allergy and Rhinology
Volume5
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Obesity
Quality of Life
Body Mass Index
Weights and Measures
Quality Improvement
Nose
Diabetes Mellitus
Asthma
Inflammation

Keywords

  • Body mass index
  • Chronic disease
  • Endoscopy
  • Obesity
  • Overweight
  • Quality of life
  • Sinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery? / Steele, Toby; Mace, Jess C.; Deconde, Adam S.; Xiao, Christopher C.; Storck, Kristina A.; Gudis, David A.; Schlosser, Rodney J.; Soler, Zachary M.; Smith, Timothy L.

In: International Forum of Allergy and Rhinology, Vol. 5, No. 12, 01.12.2015, p. 1085-1094.

Research output: Contribution to journalArticle

Steele, T, Mace, JC, Deconde, AS, Xiao, CC, Storck, KA, Gudis, DA, Schlosser, RJ, Soler, ZM & Smith, TL 2015, 'Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery?', International Forum of Allergy and Rhinology, vol. 5, no. 12, pp. 1085-1094. https://doi.org/10.1002/alr.21599
Steele, Toby ; Mace, Jess C. ; Deconde, Adam S. ; Xiao, Christopher C. ; Storck, Kristina A. ; Gudis, David A. ; Schlosser, Rodney J. ; Soler, Zachary M. ; Smith, Timothy L. / Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery?. In: International Forum of Allergy and Rhinology. 2015 ; Vol. 5, No. 12. pp. 1085-1094.
@article{33681a8d1d3b44a89a45ac3d943d24ae,
title = "Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery?",
abstract = "Background: Both obesity and chronic rhinosinusitis (CRS) are characterized by inflammation. Furthermore, both disease processes are independently associated with decreases in quality-of-life (QOL). We sought to investigate the role of comorbid obesity in QOL outcomes in CRS patients undergoing endoscopic sinus surgery (ESS). Methods: Adult patients with medically refractory CRS (n = 241) were prospectively enrolled into a multi-institutional treatment outcomes investigation. Body mass index (BMI) calculations were used to differentiate patient weight groups (normal weight: 18.5 to 24.9, overweight: 25.0 to 29.9; and obese: ≥30.0). Preoperative and postoperative QOL (Rhinosinusitis Disability Index [RSDI] and the 22-item Sino-Nasal Outcome Test [SNOT-22]) were evaluated compared across BMI groups and obesity subclasses. Results: The prevalence of comorbid obesity was 41{\%} (n = 99). Higher prevalence of comorbid disease was found across increasing BMI groups including diabetes mellitus, asthma, and depression. No significant differences were found in mean preoperative QOL measures between any BMI groups. Significant improvement between preoperative and postoperative QOL mean scores (p ≤ 0.050) was found for all BMI groups. Despite no significant difference in mean QOL improvement between BMI groups (p ≥ 0.142), overweight and obese patients reported reduced relative mean percentage ({\%}) improvement compared to normal weight participants on the RSDI total score (33{\%} and 37{\%} vs 55{\%}, respectively) and SNOT-22 total score (29{\%} and 40{\%} vs 48{\%}, respectively). Conclusion: Patients with comorbid obesity experience significant improvement in average QOL gains following ESS though the percentage of relative improvement in QOL may be decreased in patients with comorbid obesity and CRS as compared to those without.",
keywords = "Body mass index, Chronic disease, Endoscopy, Obesity, Overweight, Quality of life, Sinusitis",
author = "Toby Steele and Mace, {Jess C.} and Deconde, {Adam S.} and Xiao, {Christopher C.} and Storck, {Kristina A.} and Gudis, {David A.} and Schlosser, {Rodney J.} and Soler, {Zachary M.} and Smith, {Timothy L.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1002/alr.21599",
language = "English (US)",
volume = "5",
pages = "1085--1094",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery?

AU - Steele, Toby

AU - Mace, Jess C.

AU - Deconde, Adam S.

AU - Xiao, Christopher C.

AU - Storck, Kristina A.

AU - Gudis, David A.

AU - Schlosser, Rodney J.

AU - Soler, Zachary M.

AU - Smith, Timothy L.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: Both obesity and chronic rhinosinusitis (CRS) are characterized by inflammation. Furthermore, both disease processes are independently associated with decreases in quality-of-life (QOL). We sought to investigate the role of comorbid obesity in QOL outcomes in CRS patients undergoing endoscopic sinus surgery (ESS). Methods: Adult patients with medically refractory CRS (n = 241) were prospectively enrolled into a multi-institutional treatment outcomes investigation. Body mass index (BMI) calculations were used to differentiate patient weight groups (normal weight: 18.5 to 24.9, overweight: 25.0 to 29.9; and obese: ≥30.0). Preoperative and postoperative QOL (Rhinosinusitis Disability Index [RSDI] and the 22-item Sino-Nasal Outcome Test [SNOT-22]) were evaluated compared across BMI groups and obesity subclasses. Results: The prevalence of comorbid obesity was 41% (n = 99). Higher prevalence of comorbid disease was found across increasing BMI groups including diabetes mellitus, asthma, and depression. No significant differences were found in mean preoperative QOL measures between any BMI groups. Significant improvement between preoperative and postoperative QOL mean scores (p ≤ 0.050) was found for all BMI groups. Despite no significant difference in mean QOL improvement between BMI groups (p ≥ 0.142), overweight and obese patients reported reduced relative mean percentage (%) improvement compared to normal weight participants on the RSDI total score (33% and 37% vs 55%, respectively) and SNOT-22 total score (29% and 40% vs 48%, respectively). Conclusion: Patients with comorbid obesity experience significant improvement in average QOL gains following ESS though the percentage of relative improvement in QOL may be decreased in patients with comorbid obesity and CRS as compared to those without.

AB - Background: Both obesity and chronic rhinosinusitis (CRS) are characterized by inflammation. Furthermore, both disease processes are independently associated with decreases in quality-of-life (QOL). We sought to investigate the role of comorbid obesity in QOL outcomes in CRS patients undergoing endoscopic sinus surgery (ESS). Methods: Adult patients with medically refractory CRS (n = 241) were prospectively enrolled into a multi-institutional treatment outcomes investigation. Body mass index (BMI) calculations were used to differentiate patient weight groups (normal weight: 18.5 to 24.9, overweight: 25.0 to 29.9; and obese: ≥30.0). Preoperative and postoperative QOL (Rhinosinusitis Disability Index [RSDI] and the 22-item Sino-Nasal Outcome Test [SNOT-22]) were evaluated compared across BMI groups and obesity subclasses. Results: The prevalence of comorbid obesity was 41% (n = 99). Higher prevalence of comorbid disease was found across increasing BMI groups including diabetes mellitus, asthma, and depression. No significant differences were found in mean preoperative QOL measures between any BMI groups. Significant improvement between preoperative and postoperative QOL mean scores (p ≤ 0.050) was found for all BMI groups. Despite no significant difference in mean QOL improvement between BMI groups (p ≥ 0.142), overweight and obese patients reported reduced relative mean percentage (%) improvement compared to normal weight participants on the RSDI total score (33% and 37% vs 55%, respectively) and SNOT-22 total score (29% and 40% vs 48%, respectively). Conclusion: Patients with comorbid obesity experience significant improvement in average QOL gains following ESS though the percentage of relative improvement in QOL may be decreased in patients with comorbid obesity and CRS as compared to those without.

KW - Body mass index

KW - Chronic disease

KW - Endoscopy

KW - Obesity

KW - Overweight

KW - Quality of life

KW - Sinusitis

UR - http://www.scopus.com/inward/record.url?scp=84954378611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954378611&partnerID=8YFLogxK

U2 - 10.1002/alr.21599

DO - 10.1002/alr.21599

M3 - Article

C2 - 26201473

AN - SCOPUS:84954378611

VL - 5

SP - 1085

EP - 1094

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 12

ER -